Brian Mueller R.'s most recent trade in Biomarin Pharmaceutical Inc. - Registered Shares was a trade of 38,590 Stock Option (Right to Buy Common Stock) done . Disclosure was reported to the exchange on March 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc | Brian Mueller R. | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 38,590 | 38,590 | - | - | Stock Option (Right to Buy Common Stock) | |
| Biomarin Pharmaceutical Inc | Brian Mueller R. | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.44 per share. | 14 Mar 2025 | 18,497 | 83,141 (0%) | 0% | 69.4 | 1,284,432 | Common Stock |
| Biomarin Pharmaceutical Inc | Brian Mueller R. | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 16,640 | 99,781 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical Inc | Brian Mueller R. | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 11,040 | 82,611 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical Inc | Brian Mueller R. | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 9,660 | 92,271 (0%) | 0% | 0 | Common Stock | |
| Biomarin Pharmaceutical Inc | Brian Mueller R. | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 9,367 | 101,638 (0%) | 0% | 0 | Common Stock |